MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib

MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib

Détails bibliographiques
Auteurs principaux:	Takahashi, O, Komaki, R, Smith, P, Ryan, A, Jurgensmeier, J, Welsh, J, Jacoby, J, Hosho, K, Korshunova, M, Erez, B, Herbst, R, O'Reilly, MS
Format:	Journal article
Publié:	2009

Documents similaires

DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma
par: Gupta, A, et autres
Publié: (2013)

AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
par: Dummer, R, et autres
Publié: (2008)

Author Correction: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
par: Jin-Hang Gao, et autres
Publié: (2022-03-01)

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
par: Takahashi, O, et autres
Publié: (2012)

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis
par: Takahashi, O, et autres
Publié: (2012)

Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Model
par: Takahashi, O, et autres
Publié: (2010)

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
par: Leijen, S, et autres
Publié: (2011)

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors.
par: Leijen, S, et autres
Publié: (2011)

Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244
par: Sylwia Ammoun, et autres
Publié: (2010-01-01)

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.
par: Morelli, M, et autres
Publié: (2009)

Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
par: Medinger, M, et autres
Publié: (2009)

Resistance to Selumetinib (AZD6244) in Colorectal Cancer Cell Lines is Mediated by p70S6K and RPS6 Activation
par: Silvina Grasso, et autres
Publié: (2014-10-01)

Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas
par: Burrell, J, et autres
Publié: (2012)

Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
par: Burrell, J, et autres
Publié: (2012)

The effect of food on the single dose pharmacokinetics of cediranib
par: Jayson, G, et autres
Publié: (2008)

Multi-center randomized phase II study comparing cediranib plus gefitinib with cediranib plus placebo in subjects with recurrent/progressive glioblastoma
par: Brown, N, et autres
Publié: (2016)

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
par: Nicholas Brown, et autres
Publié: (2016-01-01)

Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology
par: Mary E. Loveless, et autres
Publié: (2012-01-01)

Computer interfacing with radial line slot arry (RLSA) antenna measurement /
par: 254621 Chin, Wen Sing
Publié: (1999)

Monitoring and quantification of rural urbanisation: Case of Arris and Theniet Elabed, Algeria
par: Soto Sabrina, et autres
Publié: (2024-01-01)

In search of an architectural genome of traditional houses: Case of the habitat of the Dechras of Arris
par: Aksas Samiha, et autres
Publié: (2023-01-01)

Fingerprint-fingervein multimodal biometric authentication system on field programmable gate arry /
par: Chong, Yew Hoe, 1992-, et autres
Publié: (2015)

Dual axis rotation solar irradiance tracking system for photovoltaic arry [electronic resource] /
par: Thanikaikumaran R. Kuppusamy, 1987-, author 646957, et autres
Publié: (2017)

The phenomenon of repetition according to Abu Al-Ala’ Al-Ma’arri in “The Chapters and Ends”
par: زهره قرباني مادواني
Publié: (2018-02-01)

Changes in perfusion and permeability in glioblastoma model induced by the anti-angiogenic agents cediranib and thalidomide
par: Jérôme Conq, et autres
Publié: (2024-08-01)

Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.
par: Merryl R Lobo, et autres
Publié: (2015-01-01)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
par: Jianling Bi, et autres
Publié: (2021-07-01)

Fingerprint-fingervein multimodal biometric authentication system on field programmable gate arry [electronic resource] /
par: Chong, Yew Hoe, 1992-, et autres
Publié: (2015)

An optical wavelength multi/demultiplexing (DWDM/CWDM) based arry waveguide grating (AWG) technique /
par: 333366 Ismahayati Adam, et autres
Publié: (2008)

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells
par: Woessner Richard, et autres
Publié: (2009-07-01)

Combined efficacy of cediranib and quinacrine in glioma is enhanced by hypoxia and causally linked to autophagic vacuole accumulation.
par: Merryl R Lobo, et autres
Publié: (2014-01-01)

Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
par: Sarah J. Welsh, et autres
Publié: (2015-03-01)

<b>Peroxidase activity in <em>Spondias dulcis</em></b> - 10.4025/actascitechnol.v32i4.6244
par: Dayse Pereira Barbosa Souza, et autres
Publié: (2010-12-01)

Normal Computed Tomography and Radiographic Study of the Nasal Cavity and Paranasal Sinuses in Shal Sheep (Ovis arries)
par: Alireza Vajhi, et autres
Publié: (2023-10-01)

Abu Ala El-Ma'arri's Opinion on Rajaz | موقف أبي العلاء المعري من الرجز
par: Ali Hasan Bahar
Publié: (2009-12-01)

Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab
par: Dante A. Suffredini, et autres
Publié: (2018-07-01)

An optical wavelength multi/demultiplexing (DWDM/CWDM) based arry waveguide grating (AWG) technique [Electronic Resource] /
par: 333366 Ismahayati Adam, et autres
Publié: (2008)

ŞAiR EBU'L- ALA EL-MA'ARRi, HAYATI, ESERLERi VE EDEBi ANLAYlŞI
par: Mustafa Kırkız
Publié: (2011-06-01)

Sastra Arab dan Disabilitas: Pendekatan Ekspresif terhadap Puisi “al-Marsiyyah” Karya al-Ma’arri
par: Tatik Mariyatut Tasnimah
Publié: (2019-06-01)

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
par: Batchelor, Tracy T., et autres
Publié: (2014)